Proyectos

CIGB 300: Proapoptotic peptide that acts on phosphorylation mediated by CK2

Heberferon: Pharmaceutical formulation for parenteral use containing IFN alfa2b and gamma. Anti-tumor action

CIGB 247: Active Immunotherapy for Cancer Treatment

CIGB 247: Active Immunotherapy for Cancer Treatment

CIGB 300: Proapoptotic peptide that acts on phosphorylation mediated by CK2

CIGB 300: Proapoptotic peptide that acts on phosphorylation mediated by CK2

CIGB 325: Proapoptotic peptide that acts on phosphorylation mediated by CK2

CIGB 552: Anti-tumor peptide targeting molecular targets

Jusvinza (CIGB 258): Therapy for COVID-19

CIGB 428: Treatment for Diabetic Neuropathy

Acellular Pertussis Vaccine

CIGB 55: IL-15 Antagonist Peptide

CR3 AIDS vaccine

CIGB 500: Cytoprotective agent of cardiac tissue

CIGB 470: Active Immunotherapy for Age-Related Macular Degeneration.

CIGB 530: Hepatic cytoprotective agent

CIGB 540: Antifibrotic peptide

Dengue vaccine

Recombinant dengue virus vaccine

Antivirals against dengue

CIGB 50: IL-15 AR vaccine

IFN Beta-Ring FCB (EM)

Interferon beta-phycocyanobilin

CIGB 210: Anti-HIV therapy

FCB stroke ring

CIGB 166: Anti-VEGF antibody

HCV Vaccine: Hepatitis C virus preventive vaccine

Antimicrobial peptides

Vaccine candidate for biological immunocastration

P0 vaccine: Protein-Based Tick Vaccine Candidate

Salvac: Vaccine candidate against sea lice, an ectoparasite of salmonids

Cunvac: Recombinant vaccine candidate against rabbit haemorrhagic disease

CIGB-552vet

Biological cytostatic for the treatment of cancer in companion animals

Transgenesis in plants

Control of geminivirus diseases in plants

CIGB-42: for the control of infectious diseases in plants

Plants as bioreactors

Obtaining soybean plants that carry the nmdef02 defensin gene and its evaluation against the Phakopsora pachyrhizi fungus

Highly thermostable biocatalyst enzymes for the production of invert syrup from sucrose

Genetic improvement of maize with biotechnological tools to sustainably increase yields in Cuba

Acuabio IV

Stimulator of the immune system and growth in aquatic organisms

Tir 8: IL-1 inhibitor

CIGB 2020: Therapy for the activation of multiple receptors of the innate immune system

CIGB 210: Therapy for COVID-19

Nasalferon: Nasal pharmaceutical solution, containing recombinant human interferon alpha 2b

Heberferon: Pharmaceutical formulation for parenteral use containing IFN alpha2b and gamma. Antiviral action.

Heberprovac: Prostate Cancer Vaccine

CIGB 845: Neuroprotective agent

Nasvac vaccine: Therapeutic recombinant vaccine

Heberprot-P: Recombinant human epidermal growth factor, for scarring

CIGB 814: Deadly type of modified peptic ligament